News
-
Mylan Pharmaceuticals ULC Launches Wixela® Inhub® (fluticasone propionate and salmeterol inhalation powder, USP), the First Available Bioequivalent Alternative to ADVAIR® DISKUS® (fluticasone propionate and salmeterol inhalation powder) in Canada
Mar 10, 2020
-
Important Safety Information on the Recall of Mylan Piperacillin-Tazobactam for Injection, 3 g/0.375 g and 4 g/0.5 g Which May Contain Particulate Matter
/>Jun 24, 2015
-
Important Safety Information on Recall of Lots of Three (3) Mylan Products for Injection Which May Contain Foreign Particulate Matter: Cisplatin Injection 1 mg/mL, Gemcitabine for Injection, USP 1g and 2 g per vial, and Topotecan HCl for Injection 4 mg per vial
Mar 16, 2015
-
Important Safety Information on Methotrexate Injection USP 50mg/2mL by Mylan Which May Contain Foreign Particulate Matter
Mar 12, 2015
-
Important Safety Information on Methotrexate Injection USP 50mg/2mL by Mylan Which May Contain Foreign Particulate Matter
Mar 12, 2015
Contact Mylan Communications
Global Communications
1000 Mylan Blvd.
Canonsburg, PA 15317
724.514.1968
communications
@mylan.com